| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| Q0WTF8 | Putative terpene synthase; | At3g29410; | NULL | 327 | arabidopsis |
| A0MJV2 | Putative uncharacterized protein; Fragment; | NULL | NULL | 93 | arabidopsis |
| A5YXZ0 | Homeodomain protein BP; Fragment; | BP; | NULL | 121 | arabidopsis |
| B0ZUE2 | Phytoalexin-deficient 4 protein; Fragment; | PAD4; | NULL | 208 | arabidopsis |
| D9IX13 | Accelerated cell death 6; | At4g14400; | NULL | 673 | arabidopsis |
| B1GUZ7 | Cinnamyl alcohol dehydrogenase; | 4CL2; | NULL | 556 | arabidopsis |
| C0Z3K2 | AT5G28020 protein; | At5g28020; | NULL | 183 | arabidopsis |
| C0Z3H2 | AT1G68190 protein; | At1g68190; | NULL | 245 | arabidopsis |
| D3K0D1 | Auxin-responsive protein; Fragment; | IAA6; At1g52830; | NULL | 155 | arabidopsis |
| E1A7C2 | Auxin-responsive protein; Fragment; | IAA9; At5g65670; | NULL | 302 | arabidopsis |
| O22228 | Putative uncharacterized protein At2g41670; | At2g41670; | NULL | 391 | arabidopsis |
| O65625 | Putative uncharacterized protein T19K4.10; | T19K4.10; | NULL | 335 | arabidopsis |
| O80681 | Putative uncharacterized protein At2g41030; | At2g41030; | NULL | 132 | arabidopsis |
| O64830 | Mutator-like transposase; | At2g23720; | NULL | 764 | arabidopsis |
| Q84WY9 | Putative uncharacterized protein At2g35200/T4C15.13; | At2g35200/T4C15.13; | NULL | 201 | arabidopsis |
| P93652 | Transcription factor L2; | atl2; | NULL | 172 | arabidopsis |
| Q8GWM2 | Putative uncharacterized protein; | NULL | NULL | 50 | arabidopsis |
| Q8H145 | Putative elongation factor; Fragment; | At1g56075; | NULL | 665 | arabidopsis |
| Q8LBJ8 | Putative uncharacterized protein; | NULL | NULL | 553 | arabidopsis |
| Q8LFM1 | Putative uncharacterized protein; | NULL | NULL | 309 | arabidopsis |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |